Trial intelligence / Profile preview

Preemptive intravenous ketamine versus acetaminophen for postoperative pain after PCNL

IRCT20170429033680N11Phase 2Completed

Sponsor
Mashhad University of Medical Sciences
Start
Nov 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label trial of ketamine and acetaminophen in postoperative pain and chronic kidney disease (CKD) (3 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoint: NVR score. Started Nov 2018; status: completed.

02

Drugs

ketamineacetaminophen
03

Conditions

postoperative painchronic kidney disease (CKD)

Beyond the preview

Go deeper on IRCT20170429033680N11.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20170429033680N11.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call